SHCNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Sotera Health Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$17.64−0.25 (-1.40%)
Close on Oct 19, 2026
- Market cap
- $5.08B
- P/E (TTM)
- 30.9
- Dividend yield
- –
Sotera Health Co revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterigenics | $211.57M | $186.14M | $198.41M | $192.85M | $194.84M | $169.68M | $179.43M | $175.57M | $176.35M | $166.50M | $172.20M | $168.35M | 65.8% | +8.6% |
| Nelson Labs | $60.66M | $51.90M | $55.20M | $55.66M | $57.07M | $52.28M | $53.98M | $58.58M | $59.00M | $57.67M | $58.21M | $54.73M | 18.9% | +6.3% |
| Nordion | $49.15M | $42.01M | $49.83M | $62.81M | $42.43M | $32.56M | $56.79M | $51.31M | $41.24M | $24.01M | $79.84M | $40.10M | 15.3% | +15.8% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterigenics | $118.13M | $96.41M | $109.99M | $107.16M | $107.75M | $88.00M | $99.59M | $95.99M | $96.78M | $85.82M | – | – | +9.6% |
| Nordion | $27.98M | $23.71M | $28.63M | $38.05M | $23.48M | $17.42M | $35.28M | $31.73M | $23.42M | $10.79M | – | – | +19.2% |
| Nelson Labs | $19.63M | $14.53M | $18.42M | $18.99M | $19.51M | $16.41M | $18.07M | $18.64M | $17.14M | $15.34M | – | – | +0.6% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $278.33M | $241.61M | $259.04M | $255.53M | $257.24M | $223.94M | $238.80M | $238.79M | $237.76M | $226.48M | $237.92M | $227.12M | 86.6% | +8.2% |
| Product | $43.05M | $38.44M | $44.40M | $55.78M | $37.10M | $30.58M | $51.41M | $46.68M | $38.84M | $21.70M | $72.32M | $36.06M | 13.4% | +16.0% |
By region
From the segment and revenue-disaggregation notes of Sotera Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.